TBPH Theravance Biopharma Inc

Theravance Biopharma Inc is a diversified biopharmaceutical company. It is engaged in discovery, research, development and commercialization of human therapeutics.

$9.06  +0.22 (2.49%)
As of 06/30/2022 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  Cayman Islands
IPO date:  05/16/2014
Outstanding shares:  75,901,646
Average volume:  447,457
Market cap:   $670,970,551
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BMNDK09
Valuation   (See tab for details)
PE ratio:   -4.72
PB ratio:   -3.74
PS ratio:   12.37
Return on equity:   41.46%
Net income %:   -268.57%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy